Novel Therapeutics Microbiome-Derived Immunotherapies for Cancer and Autoimmune Disease Molecular Therapeutics for Heterotopic Ossification Programmable RNA Delivery: Precision Targeting Platforms for Genetic Medicines Bleb–Septin Survival Hubs: Restoring Anoikis to Block Metastatic NRAS Signaling Cell Competition Therapeutics: Reprogramming the Liver to Reject Metastatic Cancer Next-Generation CAR-T for Solid Tumors: Reprogramming T Cells for Durable Cures Targeted Disruption of Cancer Metabolism and Ribosome Biogenesis through Small Molecule Precision Therapeutics Tumor-Directed RNA Therapeutics for Kidney Cancer: Overcoming Resistance with Precision siRNA Bioactive Immune Modulation for Breakthrough Peripheral Nerve Repair Cell-Specific Circadian Clocks in the Gut: A New Frontier for Intestinal Health and Chronomedicine PCDH7-Directed Antibody Therapeutics: A New Precision Target for Lung Cancer Biomarker-Guided NMNAT-2 Inhibition to Induce Proteotoxic Collapse in High-MAR Tumors Handshake Bio: Avidity-Based Biologics That Selectively Target Toxic Amyloid Conformations Reprogramming Ribosome Production to Shut Down Cancer Growth Electrolyte Therapeutics Platform: Restoring Mineral Balance to Protect the Heart and Kidneys Rare Disease Gene Therapy Platform (RDGTx): A Scalable AAV Engine for Pediatric Neurogenetic Disorders Mirofend: A First-in-Class Anti-Virulence Therapy that Disarms Staph Without Antibiotics Precision RNA Repair for Polycystic Kidney Disease Radiation-Primed In Situ Immunotherapy for Treatment-Resistant Breast Cancer Trypt-Out: Precision Nutrition to Reset Metabolism and Starve Disease LEAP2 Switchboard Therapeutics: Bidirectional Control of Ghrelin Signaling for Obesity/MASLD and ALS CATK Therapeutics: Blocking a Macrophage Protease to Prevent Vascular Collapse in Sepsis and Tissue Injury in IBD Bile-to-Islets: Making Each Patient Their Own Insulin Cell Supply Precision Metabolic Therapies for Autism Spectrum Disorders
